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Differences in the composition of the gut microbial community have been associated with diseases
such as obesity, Crohn’s disease, ulcerative colitis and colorectal cancer (CRC). We used 454
titanium pyrosequencing of the V1–V2 region of the 16S rRNA gene to characterize adherent
bacterial communities in mucosal biopsy samples from 33 subjects with adenomas and 38 subjects
without adenomas (controls). Biopsy samples from subjects with adenomas had greater numbers
of bacteria from 87 taxa than controls; only 5 taxa were more abundant in control samples. The
magnitude of the differences in the distal gut microbiota between patients with adenomas and
controls was more pronounced than that of any other clinical parameters including obesity, diet or
family history of CRC. This suggests that sequence analysis of the microbiota could be used to
identify patients at risk for developing adenomas.
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Introduction
Microbes that are associated with the human body
outnumber our own ‘human’ cells by a factor of 10
(Savage, 1977) and provide us with a wide array of
vital metabolic functions (Gill et al., 2006; Willing
et al., 2009). Recent research suggests that disrup-
tion of the human microbiome may play a crucial
role in diabetes (Burcelin et al., 2009), skin diseases
(Grice et al., 2008), obesity (Backhed et al., 2004; Ley
et al., 2005, 2006; Turnbaugh et al., 2006; Cani and
Delzenne, 2009; Tsukumo et al., 2009; Turnbaugh
and Gordon, 2009) and a range of ‘immuno-patho-
logic’ conditions including inflammatory bowel
diseases (Moore and Moore, 1995; Powrie and
Uhlig, 2004; Rakoff-Nahoum et al., 2004; Rakoff-
Nahoum and Medzhitov, 2006). Colorectal cancer
(CRC) is a prevalent malignancy within the western
countries and is the second leading cause of cancer
death in the United States (Jemal et al., 2010).
The majority (B90%) of CRC cases arise sporadi-
cally from benign adenomatous polyps (Lance,
1997). There is significant variation in the risk of
developing CRC between and within populations
and geographical regions (Lance, 1997). Although
age, tobacco and alcohol consumption, lack of
physical activity and increased body weight are
considered important risk factors for CRC (Moore
and Moore, 1995), the most significant risk factor
appears to be diet (Bingham, 2000).
The role of host-associated microbiota (Hope
et al., 2005) has also been frequently proposed as a
critical factor in CRC development (Huycke and
Gaskins, 2004; Scanlan et al., 2008). Recent techno-
logical breakthroughs now allow for the study of the
human-associated microbiome at a level of detail
that was unimaginable only a few years ago
(Margulies et al., 2005; Petrosino et al., 2009). Initial
examinations of the human-associated microbial
community with next-generation sequencing have
discovered enormous inter-personal variation in
the microbiomes of healthy individuals (Costello
et al., 2009). In this study, we used high-throughput
pyrosequencing approaches to ask how the distal
gut microbiome varies between individuals who
have colorectal adenomas compared with a control
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group without adenomas. Our results suggest that,
despite the tremendous differences between indivi-
duals in their associated microbiomes, there is a
consistent signature across subjects associated with
colorectal adenomas.
Materials and methods
Study participants, colonoscopy and biopsy
procedures
To evaluate associations between the gut microbiota
and the presence of adenomas anywhere in the
colon, we collected biopsies from normal rectal
mucosa B10–12 cm regions from the anal verge from
33 adenoma subjects and 38 adenoma-free controls.
Participants in the study were randomly selected
from the Diet and Health Study V, which included
persons age 30 years or older who underwent colono-
scopy for screening purposes at the University of
North Carolina Hospitals. Eligible subjects gave
written informed consent to provide colorectal
biopsies and a phone interview that asked questions
about diet and lifestyle. Information on diet was
obtained from a comprehensive, validated, quanti-
tative food frequency questionnaire developed at the
National Cancer Institute. A lifestyle questionnaire
collected data about demographics, medical history,
physical activity, medications and other exposures
factors from eligible participants. At the time of the
colonoscopy procedure, the research assistant
obtained anthropometric measures in order to
determine body mass index (BMI) and waist–hip
ratio (WHR).
Subjects were in generally good health when they
presented for screening. All patients received
standard instructions for preparation for colono-
scopy that included consumption of 4 l of poly-
ethylene glycol for bowel cleansing. Inclusion
criteria included visualization of the entire colon
with complete colonoscopy and a clean colon to
avoid the misclassification of cases and controls.
Exclusion criteria included colitis (either ulcerative,
Crohn’s, radiation or infectious colitis, chronic
inflammatory illnesses), previous colonic or small
bowel resection, previous colon adenomas or colon
cancer, sigmoidoscopy or incomplete colonoscopies,
familial polyposis syndrome. The enrollment pro-
cedure as well as colonoscopy and biopsy proce-
dures are similar to previously described protocols
(Keku et al., 2005; Shen et al., 2010).
Subjects were asked if they used antibiotics in the
last 3 months before colonoscopy. In all, 33 subjects
(11 controls and 22 cases) answered the question.
Among these subjects, one case subject (4.55%) and
one control subject (9.09%) reported antibiotics use.
We have no information about the specific anti-
biotics they took or why they took them. None of the
patient was on antibiotics at the time of the study.
A study pathologist examined all pathologic
specimens to confirm adenoma case status and
recorded the number of polyps, size, location and
histology. Subjects with confirmed adenomatous
polyps were classified as cases and those without
adenomas as controls. In order to avoid disturbing
the mucosa as much as possible, rectal mucosal
biopsies were collected immediately after inserting
the scope B10–12 cm from the anal verge for each
patient. The biopsies collected from all subjects
were from ‘healthy mucosa’ and not from adenomas.
Normal mucosal biopsies were rinsed in sterile
phosphate-buffered saline to ensure no contamina-
tion with fecal matter and snap-frozen in liquid
nitrogen on site. The frozen biopsies were later
transferred to  80 1C until DNA extraction. The
normal rectal biopsies from the study subjects did
not show any histology suggesting inflammation.
The study was approved by the Institutional Review
Board at the University of North Carolina, School of
Medicine (Protocol #05-3138).
DNA extraction and sequencing
Bacterial genomic DNA was extracted from mucosal
biopsies. The biopsies ranged in weight between
10–20 mg. Two biopsies per subject were used for
bacterial DNA extraction and these were placed in
lysozyme (30 mg ml 1; Sigma, St Louis, MO, USA)
for 30 min. The biopsy–lysozyme mixture was
homogenized on a bead beater (Biospec Products
Inc., Bartlesville, OK, USA) at 4800 r.p.m. for 3 min
at room temperature followed by DNA extraction
using the Qiagen DNA isolation kit (Qiagen,
Valencia, CA, USA, cat # 14123) as per the
manufacturer’s recommended protocol. The muco-
sal adherent microbiome was analyzed by Roche
(Branford, CT, USA) 454 titanium pyrosequencing of
16S rRNA tags from genomic DNAs. Pyrosequencing
(Margulies et al., 2005) was conducted at the
University of Nebraska Lincoln Core for Applied
Genomics and Ecology. We amplified the V1–V2
region (F8-R357) of the 16S rRNA gene from
mucosal biopsies followed by titanium-based pyr-
osequence analyses. The 16S primers contained the
Roche 454 Life Science’s A or B Titanium sequen-
cing adapter (italicized), followed immediately by a
unique 8-base barcode sequence (BBBBBBBB) and
finally the 50 end of primer A-8FM, 50-CCATCT-
CATCCCTGCGTGTCTC
GACTCAGBBBBBBBBAGAGTTTGATCMTGGCTCA
G-30 and B-357R, 50-CCTATCCCCTGTGTGCCTTGGC
AGTCTCAGBBBBBBBBCTGCTGCCTYCCGTA-30.
Each DNA sample was amplified with uniquely
barcoded primers, which allowed us to mix poly-
merase chain reaction (PCR) products from many
samples in a single run.
Data filtering
Sample filtering. We screened all the samples for a
batch effect that correlated with the date of
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submission to the sequencing center. Samples were
shipped on three separate dates from Chapel Hill to
the sequencing center in Nebraska. Samples shipped
on one particular date (30 September 2009) were
found to cluster separately from samples shipped on
other dates (10 June 2008 and 21 July 2008). The
DNA stocks of these two groups of samples were
also stored in different freezers at the Chapel Hill lab
(Keku lab, UNC at Chapel Hill, NC, USA). In
addition, the sum of Bacteroidetes and Firmicutes
observed in samples shipped on this date was much
lower than we would expect based on both pre-
viously published human gut microbial 454 data
sets and our own 454 data sets. Sequences generated
from samples sent to the sequencing center on this
date were therefore removed from further analysis.
Leek et al. (2010) recently showed the importance of
screening high-throughput data sets for batch effects
and screening for batch effects indeed proved useful
in removing the technical artifacts from our data set.
The characteristics of the 71 samples, selected after
sample filtering, are shown in Table 1.
Sequence filtering
Ribosomal Database Project (RDP) Pipeline: The first
step in the data analysis process involved a
preliminary QC (quality control) filter (downstream
of the Roche 454 GS-FLX software filtering). We
removed sequences from our data set if there were
any Ns in the sequence or the 50 primer did not
exactly match the expected 50 primer or if the
average quality score was o20. We then removed
the 50 primer sequence from our reads that have
survived above filtering. Only trimmed filtered
sequences with a length between 200–500 bp were
kept in our data set for RDP analysis.
Operational Taxonomic Unit (OTU) Pipeline: We
removed sequences from inclusion in the OTU data
set if there were any Ns in the trimmed sequence or
if the 50 primer did not exactly match the expected
50 primer. As recommended by Kunin et al. (2010),
sequences were end-trimmed with the Lucy algo-
rithm (Chou and Holmes, 2001) at a threshold of
0.002 (quality score of 27). Only reads with trimmed
lengths between 150 and 450 were retained for OTU
analysis. Table 2 shows the number of sequences
removed by our RDP and OTU pipelines.
Bacterial identification. The sequences in our data
set were given taxonomic assignments based on two
methods.
RDP assignment method: Sequences that have
been filtered using the RDP pipeline (Table 2) were
submitted to the RDP Classifier 2.1 algorithm for
taxonomic identification at various taxonomic
levels. Sequences assigned in each sample to
various taxa, from phylum level and genus level,
were counted at the RDP confidence threshold of 80.
OTU assignment method: OTU analysis is more
sensitive to sequencing error (Kunin et al., 2010)
and we therefore applied additional QC steps in our
OTU analysis pipeline (Table 2). Sequences filtered
through the OTU pipeline were submitted to
AbundantOTU (http://omics.informatics.indiana.
edu/AbundantOTU/) for assignment of each
Table 1 Descriptive characteristics of the study participants,
cases (33) and controls (38)
Characteristics Case (n¼33) Control (n¼ 38) P-valuea
Age (mean, s.e.) 57.45 (1.11) 55.70 (1.08) 0.26
Male (%) 60.61 50 0.54
WHR (mean, s.e.) 0.94 (0.01) 0.90 (0.01) 0.06
BMI (%)
Normal 27.27 48.65
Overweight 48.48 24.32 0.09
Obese 24.24 27.03
Caloric intake
(in kcal) (mean, s.e.)













14.9 (4.01) 13.55 (3.95) 0.81
Alcohol
(g, mean, s.e.)
11.83 (2.24) 30.29 (17.03) 0.29
Red meat
(mean, s.e.)
1.52 (0.21) 1.2 (0.18) 0.26
Total dietary fiber
(g, mean, s.e.)
22.01 (1.64) 23.94 (2.34) 0.5
Fat (g, mean, s.e.) 79.13 (6.57) 73.8 (6.33) 0.56
Calcium
(mg, mean, s.e.)
897.89 (71.88) 889.84 (70.65) 0.94
Vegetable servings
(mean, s.e.)
4.49 (0.34) 5.17 (0.49) 0.26
Fruit servings
(mean, s.e.)















Abbreviations: BMI, body mass index; CRC, colorectal cancer; NSAID,
non-steroidal anti-inflammatory drug; WHR, waist-to-hip ratio.
P-values are based on t-tests between case and control or the w2 test for
BMI category. Caloric intake is reported as kilocalories (kcal) and is
based on responses from a food frequency questionnaire50 that was
administered to subjects during phone interviews.
aAntibiotic use, percent of subjects that reported antibiotics use 3
months before colonoscopy.
bAdenomas located in the cecum, ascending colon, hepatic flexure
and transverse colon were considered proximal location while
adenomas located in the splenic flexure, descending colon, sigmoid,
rectosigmoid and rectum were considered distal. Subjects that had
had adenomas in both locations were classified as both.
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sequence to OTUs (97% identity). Sequences
assigned in each sample to various OTUs were
counted and then normalized and log transformed
(see Data Preprocessing), before proceeding to
further downstream analyses. Consensus sequences
generated by AbundantOTU during construction of
OTUs were submitted to RDP classifier 2.1 to assign
taxonomy to each of the OTU groups. Consensus
sequences of the 613 OTUs generated by Abun-
dantOTU (Supplementary File 3.txt) were also
submitted to ChimeraSlayer (Haas et al., 2011)
(http://microbiomeutil.sourceforge.net/) and the nine
consensus OTUs identified by chimera slayer
as chimeras were removed from our data set.
In addition, consensus sequences of four OTUs
on BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi)
search against the Silva reference 16S database
failed to match 497% sequence identity, so these
were also removed from further analysis. This left a
total of 600 OTUs.
Richness and evenness. Shannon–Wiener Diver-
sity Index, H, was calculated using the equation,
H¼ SPi (lnPi), where Pi is the proportion of each
species (taxa) in the sample. Richness was calcu-
lated as the number of OTUs, genera or phyla
observed in 2636 sequences (where 2636 is the
number of sequences seen in the sample with the
fewest sequences). For each sample, 2636 sequences
were randomly chosen 1000 times and the average
number of OTUs, genera or phyla observed over
these 1000 permutations was reported as richness.
Evenness measures how evenly the individuals
are distributed among the different species/taxa and
is calculated by J¼ H’/Log (S) where H’ is Shannon
diversity and S is the number of species or taxa in
each sample. Wilcoxon-tests and Student’s t-tests
were performed to compare the mean similarities of
the groups, case and control. The false discovery
rate (FDR) was set at 10% using the Benjamini and
Hochberg procedure (Benjamini and Hochberg,
1995) to avoid type 1 error due to multiple
comparisons on a single data set.
Data preprocessing. Raw counts were normalized
then log transformed using the normalization
scheme mentioned below, before proceeding with
the rest of the analyses.
LOG10 ((Raw count/number of sequences in
that sample)Average number of sequences per
sample þ 1).
Removal of rare taxa. In order to minimize the
number of null hypotheses for which we need to
correct for multiple hypothesis testing, we needed to
remove rarely occurring taxa that occurred in so few
patients that they could not be significantly asso-
ciated with case–control or obesity phenotypes. In
all of our analyses (except richness calculations), we
therefore only included taxa that occurred in at least
25% of all samples. For the RDP approach, 9 phyla
and 100 genera met this criterion. For the OTU
approach, 371 OTUs met this criterion.
Tree generation. For each of the 371 consensus
sequences from OTUs that met the above criteria,
BLASTN (http://blast.ncbi.nlm.nih.gov/Blast.cgi)
was used to find the top 10 hits in the Silva
reference tree release 104 (http://www.arb-silva.de/
download/arb-files/). In this way, we identified a set
of 3594 aligned sequences to serve as our reference
tree. The program align.seqs within MOTHUR
(http://www.mothur.org/) was used to align the
371 AbundantOTU consensus sequences that
passed all QC steps to these 3594 aligned sequences
as extracted from the Silva reference alignment.
With custom Java code based on the Archaeopteryx
code base (http://www.phylosoft.org/archaeopteryx/),
we removed all but the 3594 sequences from the
Silva reference tree. We then uploaded the align-
ment of the 3594 reference sequences plus the 371
AbundantOTU sequences to the RaxXML EPA
server (http://i12k-exelixis3.informatik.tu-muenchen.
de/raxml), which uses maximum likelihood to
place new sequences within a reference tree. Each
node in the tree was colored by FDR (Figure 3;
Supplementary Figure 4). Trees were visualized
with Archaeopteryx. Leaf nodes in Supplementary
Figure 4 are labeled with the RDP call of the
consensus sequence at 80%.
Data validation
Real-time quantitative PCR validation. qPCR pri-
mers were designed based on no o95% sequence
similarity from bacterial 16S ribosomal DNA
sequence alignments obtained from pyrosequencing.
To measure the abundance of a specific taxon, three
primer pairs where designed: one generic for all
bacterial groups (Universal Primer): [EUB341-F
50-CCTACGGGAGGCAGCAG-30; EUB518-R 50-ATT
ACCGCGGCTGCTGG-30] and three taxon-specific
primer pairs: first for the Helicobacter genus (Heli_F
50-AGTGGCGCACGGGTGAGTA-30; Heli_R 50-GTG




Total no. of sequences 600354 598645
Average/sample 8455.69 8431.62
s.d. 3840.73 3843.29
Average sequence length 343.131 343.575
OTU pipeline
Total no. of sequences 600354 532506
Average/sample 8455.69 7500.08
s.d. 3840.73 3578.55
Average sequence length 343.131 302.034
Abbreviations: QC, quality control; RDP, Ribosomal Database Project.
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TCCGTTCACCCTCTCA-30), the next one for the
Acidovorax genus (Aci_F 50-TGCTGACGAGTGGCG
AAC-30 Aci_R 50-GTGGCTGGTCGTCCTCTC-30) and
another for the Cloacibacterium genus (Clo_F 50-TG
CGGAACACGTGTGCAA-30; Clo_R 50-CCGTTACCT
CACCAACTAGC-30).
In all, 10 ml PCR reactions were prepared contain-
ing 100 ng of DNA extracted from colonic mucosal
biopsies, 10 mM of each primer and 5ml of Fast-SYBR
Green Master Mix (Applied Biosystems, Carlsbad,
CA, USA). Cycling conditions were: 1 cycle at 95 1C
for 10 min followed by 45 cycles of 95 1C for 15 s,
60 1C for 1 min, and 72 1C for 30 s. A single
dissociation curve cycle was run as follows: 95 1C
for 30 s, 60 1C for 30 min, and 90 1C for 30 s. A pool of
samples was prepared to serve as the standard for
the qPCR by mixing equal volumes from each
sample. Abundance of a specific taxon was calcu-
lated by the delta–delta threshold cycle (DDCt)
method (Livak and Schmittgen, 2001) in which:
DDCt¼ (CtTSE – CtUE) – (CtTSP – CtUP)
Where: CtTSE: Ct of experimental samples for
taxon-specific primers, CtUE: Ct of experimental
samples for universal primer, CtTSP: Ct for DNA Pool
for taxon-specific primers, CtUP: Ct for DNA pool for
universal primers. Theoretically, the abundance of a
taxon is 2ddCt.
Statistical analyses. The diversity indices, rich-
ness and evenness, were calculated using JAVA
implementations (see Supplementary File 2). Kruskal–
Wallis, Wilcoxon and Student’s t-tests were performed
using JMP 8.0 (SAS Institute, Cary, NC, USA) to
compare the mean similarities of the groups, case and
control. Regression and correlation analyses were
performed using JMP 8.0 (SAS Institute) and in R
(Open Sourced Statistical software, Vienna, Austria).
Results
We analyzed the adherent microbiota from mucosal
biopsies of 33 adenoma cases and 38 non-adenoma
controls based on the 16S rDNA genes and high-
throughput pyrosequencing methods. Case subjects
were slightly older (case 57.4 years) compared with
controls (55.7 years). Cases were more likely to have
higher WHR than controls (P¼ 0.06) and be over-
weight or obese (P¼ 0.09). There were no significant
differences between cases and controls for smoking,
fiber intake, calories, fat and other risk factors
(Table 1). The location of the adenomas were
proximal (42%), distal (42.5%) and both locations
(15.5%). Adenomas were categorized as small
(1–5 mm) medium (6–10 mm) and large (410 mm)
with 69.7% classified as small, 24.2% as medium
and 6.1% as large. The average number of adenomas
in case subjects was 1.6 (range 1–9).
Our initial analyses looked at global signatures of
the entire microbial community. At the phylum,
genus and OTU (cluster of sequences in which the
average percent identity of all of the sequences
within a cluster is X97%) levels we found sig-
nificant differences in richness (that is, the number
of taxa present in a sample), but no differences in
evenness (that is, how evenly distributed taxa are
within a sample), between cases and controls
(Figure 1; Supplementary Figures 1 and 2). In order
to see whether case samples cluster separately from
control samples, we performed principal component
analysis (PCA) of the log-normalized abundance of
the 371 OTUs that occur in at least 25% of our
samples (Figure 2; Supplemental File 1). Results
from this unsupervised clustering showed imperfect
but statistically significant clustering based on
disease status at the global level; a Wilcoxon test
performed on the first principle component from
this PCA rejected the null hypothesis that case and
control had the same distribution with a P-value of
0.0007.
We next tested which individual bacterial taxa
were different between cases and controls. By
examining the results of the RDP classification
algorithm (Wang et al., 2007) at the phylum level,
we observed at a 10% FDR threshold that cases had
higher relative abundance of TM7, Cyanobacteria
and Verrucomicrobia compared with controls
(Supplementary Table 1). At the genus level at a
10% FDR threshold, the relative abundance levels of
30 genera including Acidovorax, Aquabacterium,
Cloacibacterium, Helicobacter, Lactococcus, Lacto-




























Figure 1 Richness (left panel) and evenness (right panel) for the OTUs observed in our study for cases (n¼ 33) vs controls (n¼38).
The x axis is proportional to the number of subjects in each category. By the Wilcoxon test, cases had a significantly higher richness
(P¼ 0.0061) than controls, but there was no significant difference in evenness (P¼ 0.36).
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controls (Supplementary Table 2). Remarkably, only
one genus, Streptococcus, had a higher relative
abundance in the control group. In order to validate
these pyrosequencing results, we developed qPCR
assays for a subset of observed genera that were
significantly different in their relative abundances
between cases and controls (that is, Helicobacter
spp., Acidovorax spp. and Cloacibacteria spp.). We
observed the expected correlations between the two
methods (Supplementary Figure 3), validating the
results of our pyrosequencing approach.
We next performed an analysis of OTUs, which
are clusters of sequences in which the average
percent identity of all of the sequences within a
cluster is X97%. Our analysis at the OTU level at a
10% FDR threshold found 87 OTUs with signifi-
cantly higher relative abundance in cases vs controls
and only five OTUs higher in controls
(Supplementary Table 3). When we used the RDP
classification algorithm to classify the consensus
sequence for each of the 92 significantly different
OTUs, bacteria with higher relative abundance in
cases were mostly members of the phyla Firmicutes
(42.6%), Bacteroidetes (25.5%) and Proteobacteria
(24.5%) (Figure 3; Supplementary Figure 4). A rank-
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Component 1  (18.8 %)
Figure 2 PCA on the normalized log abundances of taxa at the
OTU level. Only the 371 OTUs that are present in at least 25% of
all samples were included in the analysis. Component 1 explains
18.81% of all variance while component 2 explains 6.76% (red¼
case; green¼ control).
Figure 3 Maximum likelihood tree generated from the 371 OTUs in which the OTU was observed in at least 25% of our patients. The
tree was generated using the RaxXML EPA server (http://i12k-exelixis3.informatik.tu-muenchen.de/raxml) (see Materials and methods).
Branches are colored based on RDP Phylum level assignments. Red-colored branches represent OTUs significantly different between
cases and controls within each Phylum (at 10% FDR).
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ences between cases and controls (significant at
10% FDR) are entirely in low-abundance taxa
(Supplementary Figure 5). This observation
explains why there are differences between case
and control in richness (Figure 1), which depends
on the total number of taxa observed, but not
evenness, which is more sensitive to changes in
high-abundance taxa.
To determine if the microbial differences seen
between the cases and controls correlate with
clinical metadata associated with the samples, we
performed either regressions (for the continuous
variable; Table 3a) or t-tests (for binary categorical
variables; Table 3b) between each metadata category
and the first principle component from our sequen-
cing data PC1, generated by collapsing the 371 OTUs
that are present in at least 25% of our samples
(Figure 2). As shown in Tables 3a and b, PC1 does
not show any significant correlation with any of the
clinical categories at a 10% FDR except for the
disease status (case–control) category, which would
be significant even a FDR threshold of 1%
(Table 3b). In addition, we performed correla-
tions (for the continuous variables; Table 4a) and
Wilcoxon/Kruskal–Wallis tests (for binary categori-
cal variables; Table 4b) between the microbial
richness of each sample and the metadata associated
with that sample; the results from these tests show
that there was no difference in richness with any
of the metadata categories associated with our
subjects apart from disease (case/control) status
(Tables 4a and b).
Since obesity is a risk factor for development of
CRC, and changes in the human microbiome have
previously been associated with obesity (Turnbaugh
et al., 2009; Zhang et al., 2009) we further evaluated
the relationship between the relative abundance
levels of the individual taxa and BMI and WHR.
We classified subjects into one of the three
BMI categories; normal (BMI o25), overweight
(BMI¼ 25–29) and obese (BMI X30) and three
WHR levels; low, medium and high based on
accepted thresholds (http://www.bmi-calculator.
net/waist-to-hip-ratio-calculator/waist-to-hip-ratio-
chart.php). For each OTU, the non-parametric
Kruskal–Wallis test was performed between the
three groups for BMI and WHR. There were no
OTUs that showed significant differences between
the various BMI and WHR risk factor categories even
if we were to set a FDR threshold as high as o200%
(Supplementary Tables 4 and 5). Likewise, there
were no significant differences in the diversity
measures, richness and evenness, between the
various risk factor categories (Figures 4 and 5).
Finally, regressions between BMI values and WHR
values against each taxa at the OTU level also
showed no significant association between the
Table 3a Regressions between continuous clinical parameters associated with the samples and the first principal component (PC1)
Metadata category R2 P-value RANK (nP)/R Slope
Total number of veg servings 0.056346 0.0569 1 0.68280 0.843878
Total dietary fiber (g) 0.028880 0.1759 2 1.05540 0.127379
Age 0.012339 0.3599 3 1.43960 0.144368
Calcium (mg) 0.011747 0.3901 4 1.17030 0.002297
Waist-to-hip ratio 0.010132 0.4036 5 0.96864 10.321238
Body mass index 0.009079 0.4327 6 0.86540 0.166502
Total number of fruit servings 0.004159 0.6098 7 1.04537 0.275328
NSAIDS use (per month) 0.003517 0.6443 8 0.96645 0.022870
Red meat 0.001908 0.7297 9 0.97293 0.005771
Total fat (g) 0.001291 0.7763 10 0.93156 0.012833
Alcohol (g) 0.000052 0.9545 11 1.04127 0.000902
Caloric intake (kcal) 0.000015 0.9753 12 0.97530 0.000029
Abbreviations: NSAID, non-steroidal anti-inflammatory drug; OTU, Operational Taxonomic Unit; PCA, principal component analysis.
PC1 was generated by PCA for the 371 OTUs that have at least one sequence assigned to them in at least 25% of the samples (Figure 5). P-values
are from linear regression. The last column shows correction for multiple hypothesis testing (Abbolito et al., 1992) using (nP)/R, where n¼ total
number of continuous metadata variables tested, P¼ raw P-value and R¼ sorted rank of the metadata variable.
Table 3b Wilcoxon/Kruskal–Wallis tests on the first principal
component (PC1) based on the subgroupings of the categorical





Disease status (case, control) 0.00070 1 0.00490






Diabetes history 0.46360 4 0.81130
Ever smoked 0.74140 5 1.03796
Sex 0.86240 6 1.00613
Antibiotics use 0.93990 7 0.93990
Abbreviations: OTU, Operational Taxonomic Unit; PCA, principal
component analysis.
PC1 was generated by PCA for the 371 OTUs that have at least one
sequence assigned to them in at least 25% of the samples (Figure 5).
P-values are from the Wilcoxon/Kruskal–Wallis on the first principle
component. The last column shows correction for multiple
hypothesis testing (Abbolito et al., 1992) using (nP)/R, where
n¼ total number of categorical metadata variables tested, P¼ raw
P-value and R¼ sorted rank of the metadata variable.
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OTUs with either BMI (Supplementary Figure 6) or
WHR (Supplementary Figure 7) at an FDR threshold
of o10% (Supplementary Tables 6 and 7).
Discussion
In a recent study, in which we used the more limited
T-RFLP fingerprinting and traditional clone sequen-
cing methods, we reported Firmicutes, Bacteroi-
detes and Proteobacteria as the predominant phyla
in colonic mucosa (Shen et al., 2010). These
findings are compatible with our current observa-
tions where we used a more advanced sequencing
technology to gain better insights into the relation-
ship between mucosal adherent bacteria and adeno-
mas. The depth of sequencing and the larger sample
size in this study provides better coverage and a
better understanding of the overall structure and
composition of the microbiota. For instance, the
phylum Actinobacteria was not detected in our
previous study (Shen et al., 2010) but was detected
in this study. The current case–control study found
a large number of differences within the microbial
community between adenoma case and non-control
subjects with higher microbial richness in cases
than controls. In particular, we found increased
relative abundance of potential pathogens such as
Pseudomonas, Helicobacter and, Acinetobacter
(Supplementary Table 2; Supplementary Table 3)
and other genera belonging to the phylum Proteo-
bacteria (Figure 2). The presence of these potential
pathogens may directly increase the risk of adenoma
development by changing the gut environment. For
example, Helicobacter has a much higher relative
abundance in cases vs controls (Supplementary
Tables 2 and 3) consistent with previous studies,
which implicate this bacterium in colorectal adeno-
mas (Zumkeller et al., 2006; Burnett-Hartman et al.,
2008; Takakura et al., 2008); a possible explanation
for this association is that this microbe alters the pH
of the gastrointestinal tract (Abbolito et al., 1992;
Chen et al., 1997). Acidovorax spp., one of the
bacterial signatures identified as significantly dif-
ferent between case and control in this study, is a
flagellated, gram negative acid degrading member of
the phylum Proteobacteria. Although, not much is
known about its clinical epidemiology and patho-
genicity in humans, it has been reported to also
degrade nitro-aromatic compounds (Malkan et al.,
2009). A potential mechanism for the Acidovorax–
adenoma association could relate to the induction of
local inflammation by increased flagellar proteins
resulting from the higher abundance of Acidovorax
(Tanaka et al., 2003; Takakura et al., 2008).
Another potential mechanism could be related to
changes in the local gut environment that favors
increased abundance of specific taxa. For example,
acid producing bacteria such as Lactobacillus, are
known to lower the gut pH and regulate the growth
of other bacteria. It is possible that the increased
abundance of Lactobacillus could influence levels of
Acidovorax that have the ability to degrade acid
produced by Lactobacillus as a carbon source.
Table 4a Regressions between continuous clinical parameters associated with the samples and the richness index of each sample
Metadata category R2 P-value RANK (nP)/R Slope
Total_number_of_veg_servings 0.059915 0.0556 1 0.66720 6.12603
Total_dietary_fiber_(g) 0.022133 0.2369 2 1.42140 0.805456
Waist-to-hip ratio 0.013745 0.3295 3 1.31800 86.42771
Body mass index 0.000900 0.4319 4 1.29570 1.191711
Red meat 0.007795 0.4843 5 1.16232 4.827834
Calcium (mg) 0.007269 0.4995 6 0.99900 0.013053
NSAIDs use (per month) 0.007103 0.5114 7 0.87669 0.237458
Total_number_of_fruit_servings 0.006869 0.5116 8 0.76740 2.555904
Total_fat (g) 0.005034 0.5744 9 0.76587 0.119564
Age 0.003732 0.6154 10 0.73848 0.569015
Alcohol (g) 0.000157 0.7541 11 0.82265 0.035803
Caloric intake (kcal) 0.001225 0.782 12 0.78200 0.001853
Abbreviation: NSAID, non-steroidal anti-inflammatory drug.
The richness index was calculated as described in the methods section. P-values are from linear regression. The last column shows correction
for multiple hypothesis testing (Abbolito et al., 1992) using (nP)/R, where n¼ total number of continuous metadata variables tested, P¼ raw
P-value and R¼ sorted rank of the metadata variable.
Table 4b Wilcoxon/Kruskal–Wallis tests on the richness indices
based on the subgroupings of the categorical clinical parameters





Disease status (case, control) 0.00610 1 0.04270




Diabetes history 0.55390 4 0.96933
Ever smoked 0.81520 5 1.14128
Sex 0.81720 6 0.95340
Antibiotics use 0.88010 7 0.88010
Abbreviation: CRC, colorectal cancer.
The last column shows correction for multiple hypothesis testing
(Abbolito et al., 1992) using (nP)/R, where n¼ total number of
categorical metadata variables tested, P¼ raw P-value and R¼ sorted
rank of the metadata variable.
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Interestingly, we observed that Lactobacillus was
more abundant in cases than controls. Lactobacillus
is considered a beneficial microbe (Gibson and
Roberfroid, 1995; Duncan et al., 2004) with rela-
tively low abundance in the gut (Eckburg et al.,
2005). We propose that Lactobacillus spp. may
induce changes in the adherent ecosystem that
could alter the pH to create favorable conditions
for bacterial dysbiosis. This is consistent with
suggestions by Duncan et al. (2004) that bacteria
that grow in acidic pH create an environment that
can be exploited by more low pH-tolerant microbes.
Cloacibacterium, another bacterium that differed
significantly between case and control at the genus
level, is a gram negative anaerobe. It is a Flavobac-
terium that belongs to the phylum Bacteroidetes and
plays an important role in breaking down complex
organic matter (Bernardet et al., 2002). Disruption of
homeostasis in the adherent ecosystem may also
account for the higher abundance of Cloacibacte-
rium. Although we found that several bacterial
genera were associated with colorectal adenomas
and the exact mechanisms for bacterial dysbiosis–
adenoma relationship are not well defined, we have
attempted to suggest potential mechanisms and
highlight a few genera. Other factors that change
the colonic environment such as diet and host
factors could also contribute to the bacterial dysbio-
sis and adenoma association. We recognize that
there is limited information about the function
of most of these bacteria as such our findings will
need to be verified in a future studies. While these
findings provide important clues to the relationship
between microbial diversity and colorectal adeno-
mas, the case–control design limits our ability to
assess causality. However, our findings have the
potential to inform future studies in animal models
to evaluate mechanisms.
Taken together, these findings demonstrate that
the presence of adenomas is associated with changes
in the relative abundance of various taxa, including
potential pathogens, present in the gut mucosa and
that these changes are not significantly correlated
with other clinical parameters such as obesity levels
(WHR and BMI), age, NSIAD use and antibiotic use
(Tables 3 and 4). Previous metagenomic studies have
implicated the composition of the microbial com-
munity as contributing to obesity (Ley et al., 2005,
2006; Turnbaugh et al., 2006; Turnbaugh and
Gordon, 2009; Turnbaugh et al., 2009) although this
has been controversial (Larsen et al., 2010). In our
study, we did not see any statistically significant
relationship between BMI or WHR and any indivi-
dual taxa within the microbial community (Figures
4 and 5; Supplementary Tables 4–7). Likewise, when
we examined our data for a relationship between
BMI and the Firmicutes to Bacteroidetes ratio, we
observed no such correlation (data not shown).
These results stand in contrast to previous studies
that have observed that BMI is associated with the
increased presence of Firmicutes (Turnbaugh et al.,
2006; Turnbaugh and Gordon, 2009). It is unclear
whether regional differences in subjects (all of our




























Figure 5 Richness (left panel) and evenness (right panel) at the OTU level, in low-risk (n¼25) vs medium-risk (n¼16) vs high-risk
(n¼ 30) WHR categories. No significant difference was seen by the Kruskal–Wallis test in richness (P¼0.26) or evenness (P¼ 0.76)




























Figure 4 Richness (left panel) and evenness (right panel) at the OTU level, in normal (n¼27) vs overweight (n¼ 25) vs obese (n¼ 18)
BMI categories. No significant difference was seen by the Kruskal–Wallis test in richness (P¼0.21) or evenness (P¼ 0.42) between the
three categories.
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sampling (stool sampling vs biopsies) can explain
some of the differences between our work and
previous results. We also cannot rule out the
possibility that BMI or other factors might have
achieved a statistically significant influence over the
composition of the microbial community with a
larger sample size than we had in our study. What
seems inarguable from our data set, however, is that
case–control status is asserting a larger degree of
influence on the microbial community than any of
the other clinical parameters that we collected
(Tables 3 and 4). This observation suggests that
conditions associated with adenoma formation are
more strongly linked with the microbial community
membership and structure, across patients, than any
of the other factors that we evaluated. These
observations are consistent with the idea that while
healthy individuals have a great deal of inter-
personal variation in their microbiome (Costello
et al., 2009), disease states have a specific microbial
signature.
Our observation that the microbial signature
associated with adenomas is largely distinct from
that associated with obesity suggests that next-
generation sequencing of microbial communities
may have considerable value in predicting the
actual presence of adenomas. A strength of this
study is the use of high-throughput 454 pyrosequen-
cing for an in-depth evaluation of the adherent
colonic mucosal bacteria in relation to adenomas.
Two recent papers (Castellarin et al., 2012; Kostic
et al., 2012), using similar high-throughput methods
have independently found that Fusobacterium is
associated with tissue from colorectal carcinomas.
In addition, recent studies (Marchesi et al., 2011;
Sobhani et al., 2011) compared the tissues of colonic
tumors with non-malignant mucosa and found
substantial differences in the associated microbiota.
Together with our results, which describe differ-
ences in the microbiota from normal rectal mucosa
of adenoma cases and controls, a picture is begin-
ning to develop that link microbial changes to
colorectal adenomas and cancer.
Conflict of interest
The authors declare no conflict of interest.
Acknowledgements
This research was supported, in part, by grants from the
National Institutes of Health NIH P30DK034987, R01
CA44684, P50 CA106991, R01 CA136887, K01 DK
073695. The funders had no role in study design, data
collection and analysis, decision to publish or preparation
of the manuscript.
Nucleotide sequence accession numbers: All 454 pyrose-
quence data from this study have been submitted to
Genbank database under the accession # SRS 166138.
1-172960.2.
References
Abbolito MR, Ameglio F, Guerrera AM, Citarda F, Grassi
A, Sciarretta F et al. (1992). The association of
Helicobacter pylori infection with low levels of urea
and pH in the gastric juices. Ital J Gastroenterol 24:
389–392.
Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A
et al. (2004). The gut microbiota as an environmental
factor that regulates fat storage. Proc Natl Acad Sci
USA 101: 15718–15723.
Benjamini Y, Hochberg Y. (1995). A Practical and Powerful
Approach to Multiple Testing. J Roy Stat Soc B
57: 12.
Bernardet JF, Nakagawa Y, Holmes B. (2002). Proposed
minimal standards for describing new taxa of the
family Flavobacteriaceae and emended description of
the family. Int J Syst Evol Microbiol 52: 1049–1070.
Bingham SA. (2000). Diet and colorectal cancer preven-
tion. Biochem Soc Trans 28: 12–16.
Burcelin R, Luche E, Serino M, Amar J. (2009). The
gut microbiota ecology: a new opportunity for the
treatment of metabolic diseases? Front Biosci 14:
5107–5117.
Burnett-Hartman AN, Newcomb PA, Potter JD. (2008).
Infectious agents and colorectal cancer: a review of
Helicobacter pylori, Streptococcus bovis, JC virus, and
human papillomavirus. Cancer Epidemiol Biomarkers
Prev 17: 2970–2979.
Cani PD, Delzenne NM. (2009). Interplay between obesity
and associated metabolic disorders: new insights into
the gut microbiota. Curr Opin Pharmacol 9: 737–743.
Castellarin M, Warren RL, Freeman JD, Dreolini L,
Krzywinski M, Strauss J et al. (2012). Fusobacterium
nucleatum infection is prevalent in human colorectal
carcinoma. Genome Res 22: 299–306.
Chen G, Fournier RL, Varanasi S, Mahama-Relue PA.
(1997). Helicobacter pylori survival in gastric
mucosa by generation of a pH gradient. Biophys J
73: 1081–1088.
Chou HH, Holmes MH. (2001). DNA sequence quality
trimming and vector removal. Bioinformatics 17:
1093–1104.
Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI,
Knight R. (2009). Bacterial community variation in
human body habitats across space and time. Science
326: 1694–1697.
Duncan SH, Louis P, Flint HJ. (2004). Lactate-utilizing
bacteria, isolated from human feces, that produce
butyrate as a major fermentation product. Appl
Environ Microbiol 70: 5810–5817.
Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen
L, Sargent M et al. (2005). Diversity of the human
intestinal microbial flora. Science 308: 1635–1638.
Gibson GR, Roberfroid MB. (1995). Dietary modulation of
the human colonic microbiota: introducing the con-
cept of prebiotics. J Nutr 125: 1401–1412.
Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ,
Samuel BS et al. (2006). Metagenomic analysis of
the human distal gut microbiome. Science 312:
1355–1359.
Grice EA, Kong HH, Renaud G, Young AC, Bouffard GG,
Blakesley RW et al. (2008). A diversity profile of the
human skin microbiota. Genome Res 18: 1043–1050.
Haas BJ, Gevers D, Earl AM, Feldgarden M, Ward DV,
Giannoukos G et al. (2011). Chimeric 16S rRNA
sequence formation and detection in Sanger and
Microbial richness and colorectal adenomas
N Sanapareddy et al
1867
The ISME Journal
454-pyrosequenced PCR amplicons. Genome Res 21:
494–504.
Hope ME, Hold GL, Kain R, El-Omar EM. (2005). Sporadic
colorectal cancer–role of the commensal microbiota.
FEMS Microbiol Lett 244: 1–7.
Huycke MM, Gaskins HR. (2004). Commensal bacteria,
redox stress, and colorectal cancer: mechanisms and
models. Exp Biol Med (Maywood) 229: 586–597.
Jemal A, Siegel R, Xu J, Ward E. (2010). Cancer statistics,
2010. CA Cancer J Clin 60: 277–300.
Keku TO, Lund PK, Galanko J, Simmons JG, Woosley JT,
Sandler RS. (2005). Insulin resistance, apoptosis, and
colorectal adenoma risk. Cancer Epidemiol Biomarkers
Prev 14: 2076–2081.
Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F,
Earl AM et al. (2012). Genomic analysis identifies
association of Fusobacterium with colorectal carci-
noma. Genome Res 22: 292–298.
Kunin V, Engelbrektson A, Ochman H, Hugenholtz P.
(2010). Wrinkles in the rare biosphere: pyrosequen-
cing errors can lead to artificial inflation of diversity
estimates. Environ Microbiol 12: 118–123.
Lance P. (1997). Recent developments in colorectal cancer.
J R Coll Physicians Lond 31: 483–487.
Larsen N, Vogensen FK, van den Berg FW, Nielsen DS,
Andreasen AS, Pedersen BK et al. (2010). Gut
microbiota in human adults with type 2 diabetes
differs from non-diabetic adults. PLoS One 5: e9085.
Leek JT, Scharpf RB, Bravo HC, Simcha D, Langmead B,
Johnson WE et al. (2010). Tackling the widespread and
critical impact of batch effects in high-throughput
data. Nat Rev Genet 11: 733–739.
Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight
RD, Gordon JI. (2005). Obesity alters gut microbial
ecology. Proc Natl Acad Sci USA 102: 11070–11075.
Ley RE, Turnbaugh PJ, Klein S, Gordon JI. (2006).
Microbial ecology: human gut microbes associated
with obesity. Nature 444: 1022–1023.
Livak KJ, Schmittgen TD. (2001). Analysis of relative gene
expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods 25: 402–408.
Malkan AD, Strollo W, Scholand SJ, Dudrick SJ. (2009).
Implanted-port-catheter-related sepsis caused by
Acidovorax avenae and methicillin-sensitive Staphy-
lococcus aureus. J Clin Microbiol 47: 3358–3361.
Marchesi JR, Dutilh BE, Hall N, Peters WH, Roelofs R,
Boleij A et al. (2011). Towards the human colorectal
cancer microbiome. PLoS One 6: e20447.
Margulies M, Egholm M, Altman WE, Attiya S, Bader JS,
Bemben LA et al. (2005). Genome sequencing in
microfabricated high-density picolitre reactors. Nature
437: 376–380.
Moore WE, Moore LH. (1995). Intestinal floras of popula-
tions that have a high risk of colon cancer. Appl
Environ Microbiol 61: 3202–3207.
Petrosino JF, Highlander S, Luna RA, Gibbs RA, Versalovic
J. (2009). Metagenomic pyrosequencing and microbial
identification. Clin Chem 55: 856–866.
Powrie F, Uhlig H. (2004). Animal models of intestinal
inflammation: clues to the pathogenesis of inflamma-
tory bowel disease. Novartis Found Symp 263: 164–174.
discussion 174-168, 211-168.
Rakoff-Nahoum S, Medzhitov R. (2006). Role of the innate
immune system and host-commensal mutualism. Curr
Top Microbiol Immunol 308: 1–18.
Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S,
Medzhitov R. (2004). Recognition of commensal
microflora by toll-like receptors is required for
intestinal homeostasis. Cell 118: 229–241.
Savage DC. (1977). Microbial ecology of the gastrointest-
inal tract. Annu Rev Microbiol 31: 107–133.
Scanlan PD, Shanahan F, Clune Y, Collins JK, O’Sullivan
GC, O’Riordan M et al. (2008). Culture-independent
analysis of the gut microbiota in colorectal cancer and
polyposis. Environ Microbiol 10: 789–798.
Shen XJ, Rawls JF, Randall T, Burcal L, Mpande CN,
Jenkins N et al. (2010). Molecular characterization
of mucosal adherent bacteria and associations with
colorectal adenomas. Gut Microbes 1: 138–147.
Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP,
Letulle S, Langella P et al. (2011). Microbial dysbiosis
in colorectal cancer (CRC) patients. PLoS One 6:
e16393.
Takakura Y, Che FS, Ishida Y, Tsutsumi F, Kurotani K,
Usami S et al. (2008). Expression of a bacterial
flagellin gene triggers plant immune responses and
confers disease resistance in transgenic rice plants.
Mol Plant Pathol 9: 525–529.
Tanaka N, Che FS, Watanabe N, Fujiwara S, Takayama S,
Isogai A. (2003). Flagellin from an incompatible strain
of Acidovorax avenae mediates H2O2 generation
accompanying hypersensitive cell death and expres-
sion of PAL, Cht-1, and PBZ1, but not of Lox in rice.
Mol Plant Microbe Interact 16: 422–428.
Tsukumo DM, Carvalho BM, Carvalho-Filho MA, Saad MJ.
(2009). Translational research into gut microbiota: new
horizons in obesity treatment. Arq Bras Endocrinol
Metabol 53: 139–144.
Turnbaugh PJ, Gordon JI. (2009). The core gut micro-
biome, energy balance and obesity. J Physiol 587:
4153–4158.
Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL,
Duncan A, Ley RE et al. (2009). A core gut microbiome
in obese and lean twins. Nature 457: 480–484.
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis
ER, Gordon JI. (2006). An obesity-associated gut
microbiome with increased capacity for energy har-
vest. Nature 444: 1027–1031.
Wang Q, Garrity GM, Tiedje JM, Cole JR. (2007). Naive
Bayesian classifier for rapid assignment of rRNA
sequences into the new bacterial taxonomy. Appl
Environ Microbiol 73: 5261–5267.
Willing B, Halfvarson J, Dicksved J, Rosenquist M, Jarnerot
G, Engstrand L et al. (2009). Twin studies reveal
specific imbalances in the mucosa-associated micro-
biota of patients with ileal Crohn’s disease. Inflamm
Bowel Dis 15: 653–660.
Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M,
Yu Y et al. (2009). Human gut microbiota in obesity
and after gastric bypass. Proc Natl Acad Sci USA 106:
2365–2370.
Zumkeller N, Brenner H, Zwahlen M, Rothenbacher D.
(2006). Helicobacter pylori infection and colorectal
cancer risk: a meta-analysis. Helicobacter 11: 75–80.
Supplementary Information accompanies the paper on The ISME Journal website (http://www.nature.com/ismej)
Microbial richness and colorectal adenomas
N Sanapareddy et al
1868
The ISME Journal
